While Disc Medicine Inc has underperformed by -8.97%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, IRON rose by 9.82%, with highs and lows ranging from $68.73 to $25.64, whereas the simple moving average fell by -33.21% in the last 200 days.
On February 27, 2025, TD Cowen started tracking Disc Medicine Inc (NASDAQ: IRON) recommending Buy. A report published by Morgan Stanley on November 05, 2024, Upgraded its rating to ‘Overweight’ for IRON. Raymond James also Upgraded IRON shares as ‘Strong Buy’, setting a target price of $110 on the company’s shares in a report dated November 04, 2024. Jefferies Initiated an Buy rating on October 23, 2024, and assigned a price target of $89. Scotiabank initiated its ‘Sector Outperform’ rating for IRON, as published in its report on October 16, 2024. Wells Fargo’s report from August 22, 2024 suggests a price prediction of $75 for IRON shares, giving the stock a ‘Overweight’ rating. Raymond James also rated the stock as ‘Outperform’.
Analysis of Disc Medicine Inc (IRON)
In order to gain a clear picture of Disc Medicine Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -27.73% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 21.17, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 456.82K can be a very valuable indicator of volatility for IRON stock. On a monthly basis, the volatility of the stock is set at 8.48%, whereas on a weekly basis, it is put at 20.93%, with a loss of -23.03% over the past seven days. Furthermore, long-term investors anticipate a median target price of $98.40, showing growth from the present price of $35.23, which can serve as yet another indication of whether IRON is worth investing in or should be passed over.
How Do You Analyze Disc Medicine Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 36.84%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 51.72% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
IRON shares are owned by institutional investors to the tune of 51.72% at present.
